Tech Company Financing Transactions

Ascenta Therapeutics Funding Round

Ascenta Therapeutics closed a $20 million funding round on 3/31/2008. Backers included Domain Associates, Enterprise Partners Venture Capital and Scale Venture Partners.

Transaction Overview

Company Information

Company Status

Private & Independent

Industry

Biopharmaceutical

Mailing Address

101 Lindenwood Dr. 405
Malvern, PA 19355
USA

Phone

(610) 408-0301

Website

www.ascenta.com

Email Address

[email protected]

Overview

Ascenta Therapeutics, a clinical-stage biopharmaceutical company, focuses on the discovery and development of new medicines to treat cancer.

Profile

Social Media

Company News

Facebook

YouTube

Management Team

Title

Name

Email & Social

Chief Executive Officer

Mel Sorensen

        

Chief Financial Officer

Joel Sussman

        

VP - Bus. Development

Brian Wood

        

VP - Operations

Jeffrey Brill

        

Browse more venture capital transactions:

Prev: 3/31/2008: Intelligent Bio-Systems venture capital transaction
Next: 3/31/2008: Pequot EnzymeRx Investment venture capital transaction

Share this article

Where The Data Comes From

We do our best to report on tech company VC transactions. VC investment data records on this site are sourced from a variety of public sources. The information is sourced from VentureDeal.com, an affiliated venture.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary